QT interval prolongation and its related factors before and after receiving lopinavir-ritonavir in the COVID-19 era: a historical cohort study. [PDF]
Jangjou A +7 more
europepmc +1 more source
Repurposing anti-retroviral drugs to treat NF2-related tumours: a protocol for a phase 0 trial (RETREAT). [PDF]
Campbell S +9 more
europepmc +1 more source
Pharmacokinetics of Dexamethasone in Tuberculous Meningitis. [PDF]
Calderin JM +9 more
europepmc +1 more source
Effectiveness and safety of darunavir and lopinavir for treating children and adolescents living with HIV: a systematic review. [PDF]
O'Rourke J +10 more
europepmc +1 more source
Development of an adult whole-body PBPK model of irinotecan and its metabolites for predicting UGT1A1/CYP3A-mediated drug-drug interactions. [PDF]
Chen B +9 more
europepmc +1 more source
HIV-1 Resistance to Dolutegravir in Benin: The Need to Improve and Strengthen Therapeutic Patient Education Strategies to Achieve the Third Objective 95 of UNAIDS 95-95-95 Target. [PDF]
Tchiakpe E +4 more
europepmc +1 more source
Effects of Ritonavir, Lopinavir, and Alcohol on ABC Transporters and Secretion of Bile Acid and Bilirubin in Senescent Hepatocytes. [PDF]
Chen L, Duran E, Headrick D, Ji C.
europepmc +1 more source
In Vitro Validation of Size-Dependent Antiviral Activity of <i>Phaeodactylum tricornutum</i>-Derived Peptide Fractions Against SARS-CoV-2. [PDF]
Cañedo-Figueroa DM +15 more
europepmc +1 more source
Hyperlipidemia and associated risk factors among people living with HIV on antiretroviral therapy: a retrospective cohort study from Eastern China. [PDF]
Cheng W +6 more
europepmc +1 more source
Zmpste24 deficiency contributes to intervertebral disc degeneration by undermining the stability of the nuclear membrane of nucleus pulposus cells. [PDF]
Han C, Fu S, Wang H, Zhang K, Zhao J.
europepmc +1 more source

